Milan, Italy

Pierlucio Anelli


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierlucio Anelli: Innovator in X-ray Contrast Media

Introduction

Pierlucio Anelli is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medical imaging, particularly in the development of opacifying components for X-ray contrast media. His innovative work has led to the filing of a patent that showcases his expertise and creativity.

Latest Patents

Anelli holds a patent for a compound described as 5,5'-/(1,3-propanediyl) - wherein R, R', R.sub.1, and R.sub.1 ', which are the same or different, are H, C.sub.1 -C.sub.4 alkyl, linear or branched C.sub.1 -C.sub.4 mono- or polyhydroxyalkyl. The patent also details that R.sub.2, R.sub.2 ', R.sub.3, and R.sub.3 ', which are the same or different, are one of the groups of formula --CH.sub.2 CH.sub.2 OH, --CH.sub.2 CH(OH) CH.sub.2 OH --CH(CH.sub.2 OH)CH(OH)CH.sub.2 OH, --CH.sub.2 (CHOH).sub.4 CH.sub.2 OH, or --CH(CH.sub.2 OH).sub.2. Additionally, X is one of the groups --CH(OH)--, --CH(CH.sub.2 OH)--, --C(OH) (CH.sub.2 OH)--, or --C(CH.sub.2 OH).sub.2 --. This patent is particularly useful in enhancing the effectiveness of X-ray contrast media.

Career Highlights

Anelli is associated with Dibra S.p.a., where he continues to work on innovative solutions in the medical field. His career is marked by a commitment to advancing technology that improves diagnostic imaging.

Collaborations

Throughout his career, Anelli has collaborated with notable colleagues such as Marino Brocchetta and Fulvio Uggeri. These partnerships have contributed to the development of his innovative ideas and patents.

Conclusion

Pierlucio Anelli is a distinguished inventor whose work in X-ray contrast media has made a significant impact in the medical imaging field. His patent reflects his innovative spirit and dedication to improving healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…